Table 3.
Unadjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for associations between treatment and lymph node detection methods and RFS. NAT/VBT no adjuvant therapy/vaginal brachytherapy; LND lymph node dissection; RP retroperitoneal
| Recurrence (%) | Vaginal | RP | Distant | HR (95%CI) | |
|---|---|---|---|---|---|
| Treatment | |||||
| NAT/VBT (n=76) | 5 (6.6) | 1 | 2 | 2 | 1.00 |
| EBRT (n=21) | 1 (4.8) | 1 | 1 | 0.56 (0.13, 2.36) | |
| Chemo +/− RT (n=78) | 3 (3.9) | 2 | 0.68 (0.08, 5.87) | ||
|
| |||||
| SLN Dissection | |||||
| SLN only (n=90) | 5 (5.6) | 1 | 2 | 2 | 1.00 |
| SLN + pelvic LND (n=38) | 2 (5.3) | 0 | 0 | 2 | 0.72 (0.14, 3.72) |
| SLN+ pelvic +aortic LND (n=47) | 2 (4.3) | 0 | 1 | 1 | 0.84 (0.16, 4.34) |
|
| |||||
| ITC Detection | |||||
| H&E (n=85) | 6 (7.1) | 1 | 2 | 3 | 1.00 |
| IHC (n=89) | 3 (3.4) | 0 | 2 | 1 | 0.48 (0.12, 1.93) |